Pwodwi manifaktirè & Founisè - Lachin pwodwi faktori

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Pite ≥99.0% Pite ≥98.0% (HPLC) API Pite Segondè

Non Chimik: Lasofoxifene Tartrate

CAS: 190791-29-8

Aparans: poud blan ak blan

Pite chiral: ≥99.0%Pite: ≥98.0% (HPLC)

Nan tretman osteyopowoz la nan postmenopoz

API meyè kalite, pwodiksyon komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
Imatinib Mesylate CAS 220127-57-1 Assay 98.0% ~ 102.0% Ph + CML API Faktori Segondè Kalite

Non chimik: Imatinib Mesylate (fòm alfa)

CAS: 220127-57-1

Aparans: poud cristalline blan pou blan

Esè HPLC: 98.0% ~ 102.0%

Imatinib Mesylate nan tretman Philadelphia Chromosome-Pozitif kwonik lesemi myeloid (Ph + CML)

API meyè kalite, pwodiksyon komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Entèmedyè Pite Segondè

Non: N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea

Sinonim: Imatinib Mesylate Intermediate

CAS: 152460-10-1

Aparans: limyè zoranj poud jòn poud kristal

Pite: ≥98.0% (HPLC)

Entèmedyè nan Imatinib Mesylate (CAS: 220127-57-1) nan tretman Philadelphia Chromosome-Pozitif kwonik lesemi myeloid (Ph + CML)

Inquiry: alvin@ruifuchem.com

ankèt detay
4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Entèmedyè Pite segondè

4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid Dihydrochloride

CAS: 106261-49-8

Aparans: blan pou prèske blan poud kristal

Pite: ≥98.0% (HPLC)

Entèmedyè nan Imatinib Mesylate (CAS: 220127-57-1) nan tretman Philadelphia Chromosome-Pozitif kwonik lesemi myeloid (Ph + CML)

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
N-(2-Methyl-5-nitrophenyl)-4-(piridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Entèmedyè Pite segondè

N-(2-Methyl-5-nitrophenyl)-4-(piridin-3-yl)pirimidin-2-amine

CAS: 152460-09-8

Aparans: jòn oswa prèske jòn poud

Pite: ≥98.0% (HPLC)

Entèmedyè nan Imatinib Mesylate (CAS: 220127-57-1) nan tretman Philadelphia Chromosome-Pozitif kwonik lesemi myeloid (Ph + CML)

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Pite ≥99.0% (HPLC) Favipiravir Entèmedyè COVID-19

Non chimik: 3,6-Dichloropyrazine-2-Carbonitrile

CAS: 356783-16-9

Aparans: Pale jòn poud blan poud

Pite: ≥99.0% (HPLC)

Entèmedyè nan Favipiravir (CAS: 259793-96-9) nan tretman pasyan ki gen COVID-19 rekòmande pa OMS.

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Pite ≥99.0% (HPLC) Favipiravir Entèmedyè COVID-19

Non chimik: 3,6-Difluoropyrazine-2-Carbonitrile

CAS: 356783-28-3

Aparans: Pale jòn poud blan poud

Pite: ≥99.0% (HPLC)

Entèmedyè nan Favipiravir (CAS 259793-96-9) nan tretman Enfeksyon Viris Grip ak COVID-19.

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Pite ≥99.0% Favipiravir Entèmedyè COVID-19

Non Chimik: Diethyl Aminomalonate Hydrochloride

CAS: 13433-00-6

Aparans: White oswa Off-White Crystalline Powder

Pite: ≥99.0%

Entèmedyè nan Favipiravir (CAS: 259793-96-9) nan tretman pasyan ki gen COVID-19 rekòmande pa OMS.

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
2-Aminopropanediamide CAS 62009-47-6 Favipiravir Entèmedyè COVID-19 Segondè Pite

Non chimik: 2-Aminopropanediamide

CAS: 62009-47-6

Aparans: Limyè jòn poud

Pite: ≥98.0% (LCMS-ELSD)

Entèmedyè nan Favipiravir (CAS: 259793-96-9) nan tretman pasyan ki gen COVID-19 rekòmande pa OMS.

Segondè Kalite, Pwodiksyon Komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
Favipiravir CAS 259793-96-9 T-705 Pite ≥99.0% (HPLC) COVID-19 API Faktori Segondè Kalite

Non Chimik: Favipiravir;T-705

CAS: 259793-96-9

Aparans: poud blan ak blan

Pite: ≥99.0% (HPLC)

Nan tretman Enfeksyon Viris Grip ak COVID-19

API meyè kalite, pwodiksyon komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay
Cetrorelix Acetate CAS 130143-01-0 GnRH Antagonist Peptide Pite (HPLC) ≥98.0% Segondè Kalite

Non chimik: Cetrorelix Acetate

CAS: 130143-01-0

Aparans: poud blan

Pite peptide (HPLC): ≥98.0%

Antagonist sentetik reseptè GnRH

GMP Peptides, API, meyè kalite

Kontakte: Dr Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ankèt detay
Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Non chimik: Deslorelin Acetate

CAS: 57773-65-6

Aparans: poud blan oswa poud prèske blan

Pite peptide (HPLC): ≥98.0% (pa entegrasyon zòn)

Kontni Peptid (N%): ≥80.0%

Egzamen: 95.0% ~ 105.0% (Pa anidrid, asid Acetic-gratis)

Agonis GnRH

Inquiry: alvin@ruifuchem.com

ankèt detay
Octreotide Acetate CAS 83150-76-9 Peptide Pite (HPLC) ≥98.0% API High Quality

Non Chimik: Octreotide Acetate

CAS: 83150-76-9

Aparans: poud blan

Pite peptide (pa HPLC): ≥98.0%

Esè: 95% ~ 105%

Akromegali ak timè gastroenteropankreyas

Kontakte: Dr Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ankèt detay
Sodyòm Valproate (VPA) CAS 1069-66-5 API Faktori Segondè Pite

Non chimik: Valproate sodyòm (VPA)

Sinonim: Valproic Asid Sodyòm Sèl

CAS: 1069-66-5

Aparans: blan oswa prèske blan Crystalline poud, igroskopik

Esè: 98.5% ~ 101.0% (titrasyon)

Yon Dwòg Anti-epileptik ki gen gwo spectre anjeneral byen tolere

API meyè kalite, pwodiksyon komèsyal

Inquiry: alvin@ruifuchem.com

ankèt detay

<< < Previous 324 325 326 327 328 329 330 Next >>> Paj 327 / 341

Pwodwi yo

Tetrabutylammonium Fliyò Triidrat CAS 87749-50-6 Pite> 99.0% (Titrasyon)

Bromur tetrabutilamonyòm (TBAB) CAS 1643-19-2 Pite> 99.0% ((Titrasyon)

Bromur amonyòm CAS 12124-97-9 Pite > 99.0% (titrasyon)

Tetra-n-Octylammonium Bromide (TOAB) CAS 14866-33-2 Pite> 98.0% (Titrasyon)

Didodecyldimethylammonium Bromide CAS 3282-73-3 Pite> 99.0% (GC)

(S)-(-)-TolBINAP CAS 100165-88-6 Pite> 98.0% (HPLC)

Dibromobis (triphenylphosphine) nikèl (II) CAS 14126-37-5 Pite > 99.0% (GC)

Tert-Amil Alkòl CAS 75-85-4 Pite > 99.5% (GC)

Tert-Butil Hydroperoxide (TBHP) (70% nan dlo) CAS 75-91-2

Sodyòm tert-butoksid CAS 865-48-5 Pite> 99.0% (T)

Lityòm tert-butoksid CAS 1907-33-1 Pite> 99.0% (Titrasyon)

Trimethyltetradecylammonium Klori CAS 4574-04-3 Pite> 99.0% (T)

Tributyltin Hydride CAS 688-73-3 Pite> 97.0% (GC) Gen 0.05% BHT kòm Stabilizer

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Pite ≥99.0% Pite ≥98.0% (HPLC) API Pite Segondè

Imatinib Mesylate CAS 220127-57-1 Assay 98.0% ~ 102.0% Ph + CML API Faktori Segondè Kalite

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Entèmedyè Pite Segondè

4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Entèmedyè Pite segondè

N-(2-Methyl-5-nitrophenyl)-4-(piridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Entèmedyè Pite segondè

3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Pite ≥99.0% (HPLC) Favipiravir Entèmedyè COVID-19

3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Pite ≥99.0% (HPLC) Favipiravir Entèmedyè COVID-19

Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Pite ≥99.0% Favipiravir Entèmedyè COVID-19

2-Aminopropanediamide CAS 62009-47-6 Favipiravir Entèmedyè COVID-19 Segondè Pite

Favipiravir CAS 259793-96-9 T-705 Pite ≥99.0% (HPLC) COVID-19 API Faktori Segondè Kalite

Cetrorelix Acetate CAS 130143-01-0 GnRH Antagonist Peptide Pite (HPLC) ≥98.0% Segondè Kalite

Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Octreotide Acetate CAS 83150-76-9 Peptide Pite (HPLC) ≥98.0% API High Quality

Sodyòm Valproate (VPA) CAS 1069-66-5 API Faktori Segondè Pite